X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (94) 94
male (75) 75
female (53) 53
middle aged (47) 47
aged (41) 41
oncology (41) 41
adult (34) 34
clinical neurology (25) 25
cancer (22) 22
chemotherapy (21) 21
treatment outcome (21) 21
tumors (19) 19
surgery (18) 18
temozolomide (18) 18
medicine & public health (17) 17
prognosis (17) 17
pathology (16) 16
magnetic resonance imaging (15) 15
retrospective studies (14) 14
urology & nephrology (13) 13
glioblastoma (12) 12
immunohistochemistry (12) 12
adolescent (11) 11
care and treatment (11) 11
diagnosis (11) 11
neoplasm staging (11) 11
prostatic neoplasms - pathology (11) 11
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
brain tumors (10) 10
radiotherapy (10) 10
brain neoplasms - drug therapy (9) 9
dacarbazine - analogs & derivatives (9) 9
neurology (9) 9
prospective studies (9) 9
recurrence (9) 9
survival (9) 9
biopsy (8) 8
follow-up studies (8) 8
gliomas (8) 8
meningeal neoplasms - pathology (8) 8
neurosciences (8) 8
prostate cancer (8) 8
urology (8) 8
analysis (7) 7
brain neoplasms - pathology (7) 7
child (7) 7
child, preschool (7) 7
clinical trials (7) 7
combined modality therapy (7) 7
expression (7) 7
glioblastoma - drug therapy (7) 7
glioma (7) 7
phase-ii (7) 7
prostatic neoplasms - surgery (7) 7
survival analysis (7) 7
survival rate (7) 7
aged, 80 and over (6) 6
diagnosis, differential (6) 6
endocrinology & metabolism (6) 6
experience (6) 6
glioblastoma multiforme (6) 6
high-grade gliomas (6) 6
infant (6) 6
malignant glioma (6) 6
metastasis (6) 6
neurosurgery (6) 6
prostatectomy (6) 6
research (6) 6
therapy (6) 6
abridged index medicus (5) 5
astrocytoma - drug therapy (5) 5
bladder cancer (5) 5
brain neoplasms - genetics (5) 5
criteria (5) 5
dacarbazine - therapeutic use (5) 5
dna methylation (5) 5
feasibility (5) 5
gene expression regulation, neoplastic (5) 5
glioblastoma - mortality (5) 5
kidney neoplasms - pathology (5) 5
management (5) 5
medulloblastoma (5) 5
mutation (5) 5
neoplasm invasiveness (5) 5
oligodendroglioma (5) 5
pediatrics (5) 5
pharmacology & pharmacy (5) 5
predictive value of tests (5) 5
procarbazine - administration & dosage (5) 5
prognostic factors (5) 5
prostatectomy - methods (5) 5
time factors (5) 5
adenocarcinoma (4) 4
adjuvant chemotherapy (4) 4
angiogenesis (4) 4
antineoplastic agents, alkylating - administration & dosage (4) 4
antineoplastic agents, alkylating - therapeutic use (4) 4
bevacizumab (4) 4
brain (4) 4
brain neoplasms - diagnosis (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neuro-Oncology, ISSN 1522-8517, 11/2018, Volume 20, Issue suppl_6, pp. vi171 - vi171
Abstract BACKGROUND Immunecheckpoint inhibitors (ICI) represent a new approach in oncology. The DNA MMRd would seem to be a predictor of ICI efficacy. We... 
Abstracts
Journal Article
The journal of clinical endocrinology and metabolism, ISSN 1945-7197, 2019, Volume 104, Issue 3, pp. 856 - 862
Journal Article
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 5, p. e19771
Journal Article
Journal Article
Acta Neurochirurgica, ISSN 0001-6268, 1/2018, Volume 160, Issue 1, pp. 49 - 55
Journal Article
The lancet oncology, ISSN 1470-2045, 2019, Volume 20, Issue 1, pp. 110 - 119
Journal Article
Journal of neuro-oncology, ISSN 1573-7373, 2016, Volume 131, Issue 2, pp. 331 - 340
Journal Article
Neuro-oncology (Charlottesville, Va.), ISSN 1522-8517, 06/2016, Volume 18, Issue suppl 3, pp. iii50.1 - iii50
Journal Article
Acta neuropathologica, ISSN 1432-0533, 2010, Volume 120, Issue 2, pp. 253 - 260
Journal Article